1. Iran Cancer Registration Report, 2008. Tehran: Ministry of Health and Medical Education, Centre for Disease Control; 2011.
2. Inaba H, Greaves M, Mullighan CG. Acute lymphoblastic leukaemia. Lancet 2013; 381 (9881): 1943-55.
3. Sumathi C, MohanaPriya D, Swarnalatha S, Dinesh, GM, Sekaran G. Production of prodigiosin using tannery fleshing and evaluating its pharmacological effects. Sci World J 2014; 2014:1–8. [
PubMed]
4. Francisco R, Pe´rez-Toma´s R, Gime`nez-Bonafe´ P, Soto-Cerrato V, Gime´nez-Xavier P, Ambrosio S. Mechanisms of prodigiosin cytotoxicity in human neuroblastoma cell lines. Eur J Pharmacol 2007; 572:111–9. [
PubMed]
5. Campàs C, Dalmau M, Montaner B, Barragán M, Bellosillo B, Colomer D, et al. Prodigiosin induces apoptosis of B and T cells from B-cell chronic lymphocytic leukemia. Leukemia 2003; 17(4):746–50. [
PubMed]
6. Soto-Cerrato V, Viñals F, Lambert JR, Pérez-Tomás R. The anticancer agent prodigiosin induces p21 WAF1/CIP1 expression via transforming growth factor-beta receptor pathway. Biochem Pharmacol 2007; 74(9):1340–9. [
Google Scholar]
7. Hassankhani R, Sam MR, Esmaeilou M, Ahangar P. Prodigiosin isolated from cell wall of Serratia marcescens alters expression of apoptosis-related genes and increases apoptosis in colorectal cancer cells. Med Oncol 2015; 32(1):366. [
PubMed]
8. Sam S, Sam MR, Esmaeillou M, Safaralizadeh R. Effective Targeting Survivin, Caspase-3 and MicroRNA-16-1 Expression by Methyl-3-pentyl-6-methoxyprodigiosene Triggers Apoptosis in Colorectal Cancer Stem-Like Cells. Pathol Oncol Res 2016; 22(4):715-23. [
PubMed]
9. Chang C-C, Chen W-C, Ho T-F, Wu H-S, Wei Y-H. Development of natural anti-tumor drugs by microorganisms. J Biosci Bioeng 2011; 111(5):501–11. [
PubMed]
10. Songia S, Mortellaro A, Taverna S, et al. Characterization of the new immunosuppressive drug undecylprodigiosin in human lymphocytes: retinoblastoma protein, cyclin-dependent kinase-2, and cyclin-dependent kinase-4 as molecular targets. J Immunol 1997; 158(8):3987-95. [
PubMed]
11. Denicourt C, Dowdy SF. Targeting apoptotic pathways in cancer cells. Science 2004; 305(5689):1411-3. [
Google Scholar]
12. Yenkejeh RA, Sam MR, Esmaeillou M. Targeting survivin with prodigiosin isolated from cell wall of Serratia marcescens induces apoptosis in hepatocellular carcinoma cells. Hum Exp Toxicol 2017; 36(4):402-11. [
PubMed]
13. Montaner B, Navarro S, Piqué M, Vilaseca M, Martinell M, Giralt E, et al. Prodigiosin from the supernatant of Serratia marcescens induces apoptosis in haematopoietic cancer cell lines. Br J Pharmacol 2000; 131(3):585-93. [
PubMed]
14. Dalili D, Fouladdel S, Rastkari N, Samadi N, Ahmadkhaniha R, Ardavan A, et al. Prodigiosin, the red pigment of Serratia marcescens, shows cytotoxic effects and apoptosis induction in HT-29 and T47D cancer cell lines. Nat Prod Res 2012; 26(22):2078-83. [
PubMed]
15. Campas C, Dalmau M, Montaner B, Barragán M, Bellosillo B, Colomer D, et al. Prodigiosin induces apoptosis of B and T cells from B-cell chronic lymphocytic leukemia. Leukemia 2003; 17(4):746-50. [
PubMed]